Table 3.
Variable | Mean (SD) |
|||
---|---|---|---|---|
Overall (n = 1255) | HF (n = 28) | AF (n = 49) | Combined (n = 65) | |
Age (year) | 65.3 ± 9.6 | 71.1 ± 7.5 | 70.9 ± 9.4 | 70.7 ± 8.6 |
Body mass index (kg/m2) | 27.6 ± 4.7 | 29.0 ± 4.2 | 28.1 ± 4.2 | 28.4 ± 4.3 |
Systolic blood pressure (mmHg) | 128.2 ± 20.7 | 134.9 ± 19.8 | 140.4 ± 21.5 | 138.2 ± 21.6 |
HDL cholesterol (mg/dL) | 50.6 ± 14.6 | 49.7 ± 12.7 | 49.8 ± 14.6 | 49.7 ± 14.3 |
Total cholesterol (mg/dL) | 194 ± 34.9 | 181 ± 27.6 | 186.6 ± 30 | 183.9 ± 29.2 |
log(BNP) (pg/mL) | 4 ± 1.19 | 5.51 ± 1.39 | 5.13 ± 1.29 | 5.14 ± 1.34 |
LV mass index (g/m1.7) | 61.3 ± 14.2 | 76.4 ± 21.4 | 69.5 ± 19.5 | 70.2 ± 18.6 |
LVEF (%) | 69 ± 7.6 | 63.7 ± 11.6 | 67.9 ± 10.9 | 67.3 ± 10.6 |
EDSR (%/ms) | 0.12 ± 0.06 | 0.10 ± 0.04 | 0.10 ± 0.04 | 0.10 ± 0.04 |
log(SRI) (ms/%) | 0.76 ± 0.60 | 1.07 ± 0.42 | 1.01 ± 0.52 | 1.00 ± 0.49 |
Variable | Proportion of participants (%) |
|||
Overall (n = 1255) | HF (n = 28) | AF (n = 49) | Combined (n = 65) | |
Men | 54.5 | 71.4 | 71.4 | 70.7 |
Race | ||||
Caucasian | 29.9 | 17.9 | 51.1 | 38.5 |
Chinese-American | 16.2 | 10.7 | 10.2 | 10.8 |
African-American | 23.9 | 21.4 | 14.2 | 16.9 |
Hispanic | 30 | 50 | 24.5 | 33.8 |
Smokers | ||||
Former | 36.5 | 51.9 | 37.5 | 42.2 |
Current | 10.8 | 11.1 | 12.5 | 10.9 |
Diabetes/impaired fasting glucose | 31.9 | 60.7 | 36.7 | 46.2 |
Use of hypertension medication | 39.5 | 50 | 55.1 | 55.4 |
Calcium score categories | ||||
0 | 44.2 | 17.8 | 16.4 | 20.1 |
1–100 | 27.6 | 25 | 28.6 | 27.6 |
101–300 | 14.1 | 14.3 | 16.3 | 15.4 |
>300 | 14.1 | 42.9 | 48.7 | 36.9 |
Shown are baseline characteristics of individuals who underwent tagged MRI at baseline and with information on conventional risk factors. For continuous variables, mean ± SD are given and for categorical variables, % are given.
SRI: strain relaxation index; EDSR: early diastolic strain rate; BNP: brain natriuretic peptide.